|
業務類別
|
Biotechnology |
|
業務概覽
|
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis. TP-04 for the potential treatment of ocular rosacea and TP-05 for potential Lyme disease prophylaxis and community malaria reduction. |
| 公司地址
| 15440 Laguna Canyon Road, Suite 160, Irvine, CA, USA, 92618 |
| 電話號碼
| +1 949 418-1801 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.tarsusrx.com |
| 員工數量
| 370 |
| Ms. Dianne C. Whitfield |
Chief Human Resources Officer |
-- |
28/04/2025 |
| Dr. Bryan Wahl, J.D.,M.D. |
General Counsel and Corporate Secretary |
-- |
28/04/2025 |
| Dr. Elizabeth Yeu-Lin, M.D. |
Chief Medical Officer |
美元 78.18K |
28/04/2025 |
| Dr. Seshadri Neervannan, PhD |
Chief Operating Officer |
美元 527.33K |
28/04/2025 |
| Dr. Bobak Azamian, M.D.,PhD |
Chairman of the Board, President and Chief Executive Officer |
美元 673.40K |
23/02/2026 |
| Mr. Aziz Mottiwala, M.B.A. |
Chief Commercial Officer |
美元 492.63K |
28/04/2025 |
| Mr. Jeffrey S. Farrow |
Principal Accounting Officer, Chief Financial Officer and Chief Strategy Officer |
美元 520.83K |
23/02/2026 |
|
|
| Mr. Scott Morrison |
Independent Director |
23/02/2026 |
| Dr. Andrew Goldberg, M.D. |
Independent Director |
23/02/2026 |
| Dr. Bobak Azamian, M.D.,PhD |
Chairman of the Board, President and Chief Executive Officer |
23/02/2026 |
| Mr. David E.I. Pyott, M.A.,M.B.A. |
Independent Director |
18/02/2026 |
| Dr. Katherine Goodrich, M.D. |
Independent Director |
23/02/2026 |
| Dr. Bhaskar Chaudhuri,PhD |
Independent Director |
23/02/2026 |
| Dr. William J. Link,PhD |
Independent Director |
23/02/2026 |
| Ms. Wendy L. Yarno, M.B.A. |
Lead Independent Director |
23/02/2026 |
|
|
|
|
